Your browser doesn't support javascript.
loading
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Di Giusto, Sara; Toffoletti, Eleonora; Bonifacio, Massimiliano; Binotto, Gianni; Miggiano, Maria Cristina; Calistri, Elisabetta; Stulle, Manuela; Ermacora, Anna; Stella, Rossella; Scaffidi, Luigi; D'Amore, Fabio; Scotton, Giorgia; Griguolo, Davide; De Matteis, Giovanna; Bertorelle, Roberta; Krampera, Mauro; Semenzato, Gianpietro; Fanin, Renato; Damiani, Daniela; Tiribelli, Mario.
Afiliação
  • Di Giusto S; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Toffoletti E; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Bonifacio M; Department of Medical Area, University of Udine, Udine, Italy.
  • Binotto G; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Miggiano MC; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Paduva, Italy.
  • Calistri E; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Stulle M; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy.
  • Ermacora A; Hematology Unit, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy.
  • Stella R; Division of Internal Medicine, Azienda Ospedaliera S. Maria Angeli, Pordenone, Italy.
  • Scaffidi L; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • D'Amore F; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Scotton G; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Paduva, Italy.
  • Griguolo D; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Paduva, Italy.
  • De Matteis G; Hematology Unit, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy.
  • Bertorelle R; Department of Life Sciences, Section of Biochemistry, University of Verona, Verona, Italy.
  • Krampera M; Immunology and Molecular Oncology, Istituto Oncologico Veneto, Padua, Italy.
  • Semenzato G; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Fanin R; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Paduva, Italy.
  • Damiani D; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Tiribelli M; Department of Medical Area, University of Udine, Udine, Italy.
Cancer Med ; 12(3): 3180-3184, 2023 02.
Article em En | MEDLINE | ID: mdl-36208021
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália